Package 0469-2660-30

{"route": ["ORAL"], "spl_id": "462f0a23-98d6-4154-b113-322008069743", "openfda": {"nui": ["N0000194090", "N0000194091"], "unii": ["83VNE45KXX"], "rxcui": ["2637141", "2637147"], "spl_set_id": ["cae9f798-24f9-4580-a4fc-e6c710cbda3c"], "pharm_class_epc": ["Neurokinin 3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["Astellas Pharma US, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0469-2660-30)  / 30 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0469-2660-30", "marketing_start_date": "20230512"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0469-2660-90)  / 90 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0469-2660-90", "marketing_start_date": "20230512"}], "brand_name": "VEOZAH", "product_id": "0469-2660_462f0a23-98d6-4154-b113-322008069743", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Neurokinin 3 Receptor Antagonist [EPC]", "Neurokinin 3 Receptor Antagonists [MoA]"], "product_ndc": "0469-2660", "generic_name": "fezolinetant", "labeler_name": "Astellas Pharma US, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VEOZAH", "active_ingredients": [{"name": "FEZOLINETANT", "strength": "45 mg/1"}], "application_number": "NDA216578", "marketing_category": "NDA", "marketing_start_date": "20230512", "listing_expiration_date": "20271231"}